Cadavid Diego
Insider transactions at 2 companies
This page shows all SEC Form 4 filings attributed to Cadavid Diego. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| XFOR | Chief Medical Officer | Award / Grant | 97,000 | — | — | Mar 1, 2022 |
| XFOR | Chief Medical Officer | Sale | 928 | — | — | Feb 11, 2022 |
| XFOR | Chief Medical Officer | Award / Grant | 8,035 | — | — | Mar 24, 2021 |
| FULC | SVP Clinical Development | Sale | 1,071 | $18.30 | $19,599 | Jul 1, 2020 |
| FULC | SVP Clinical Development | Option Exercise | 1,459 | $4.83 | $7,047 | Jun 25, 2020 |
| FULC | SVP Clinical Development | Sale | 401 | $22.00 | $8,822 | Jun 10, 2020 |
| FULC | SVP Clinical Development | Option Exercise | 451 | $4.83 | $2,178 | Jun 5, 2020 |
| FULC | SVP Clinical Development | Option Exercise | 338 | $4.83 | $1,633 | Jun 2, 2020 |
| FULC | SVP Clinical Development | Sale | 200 | $20.04 | $4,008 | May 28, 2020 |
| FULC | SVP Clinical Development | Sale | 1,860 | $18.00 | $33,480 | May 12, 2020 |
| FULC | SVP Clinical Development | Sale | 315 | $18.13 | $5,711 | Mar 2, 2020 |
| FULC | SVP Clinical Development | Sale | 2,143 | $17.33 | $37,138 | Feb 3, 2020 |